Daewoong pharmaceutical

069620.KO

115.18 USD

-1.52

-1.30%

Overview

Last close

115.18 usd

Market cap

1.33B usd

52 week high

119.37 usd

52 week low

69.54 usd

Target price

119.88 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.3077

Price/Book Value

2.3664

Enterprise Value

1.65B usd

EV/Revenue

1.6225

EV/EBITDA

14.2679

Key financials

Revenue TTM

1.02B usd

Gross Profit TTM

465.15M usd

EBITDA TTM

127.63M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1,877.36B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.